| 乳腺癌放化疗引起心脏毒性的一级预防进展 |
| |
| 引用本文： | 董新江,尚茹茹,刘晓红. 乳腺癌放化疗引起心脏毒性的一级预防进展[J]. 心血管病学进展, 2020, 0(1): 78-81 |
| |
| 作者姓名： | 董新江 尚茹茹 刘晓红 |
| |
| 作者单位： | 山西医科大学;山西医科大学附属人民医院特需病房 |
| |
| 摘 要： | 女性乳腺癌发病率和死亡率分别位居中国女性恶性肿瘤的第1位和第5位。早期诊断和规范治疗显著减少乳腺癌患者的死亡率,但乳腺癌放化疗的心脏毒性成为其死亡的主要原因之一。早期预防心脏毒性至关重要。现从以下几方面论述:评估心血管疾病风险、放射治疗策略、预防蒽环类药物心脏毒性以及β受体阻滞剂和/或血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂和他汀类药物的心脏保护作用。
|
| 关 键 词： | 乳腺癌 放化疗 蒽环类药物 曲妥珠单抗 心脏毒性 一级预防 |
Primary Prevention of Cardiotoxicity Caused by Radiotherapy and Chemotherapy for Breast Cancer |
| |
| DONG Xinjiang,SHANG Ruru,LIU Xiaohong. Primary Prevention of Cardiotoxicity Caused by Radiotherapy and Chemotherapy for Breast Cancer[J]. Advances in Cardiovascular Diseases, 2020, 0(1): 78-81 |
| |
| Authors: | DONG Xinjiang SHANG Ruru LIU Xiaohong |
| |
| Affiliation: | (Shanxi Medical University,Taiyuan 030001,Shanxi,China;Special Needed Ward of People's Hospital Affiliated to Shanxi Medical University,Taiyuan 030012,Shanxi,China) |
| |
| Abstract: | The incidence and mortality of breast cancer in women are ranked the 1 st and 5 th in female malignant tumors in China respectively. Early diagnosis and standardized treatment have significantly reduced the mortality of breast cancer patients,but cardiotoxicity of breast cancer with radiotherapy and chemotherapy has become one of the leading causes of death. Early prevention of cardiotoxicity is essential. This review will discuss the following aspects: assessment of cardiovascular disease risk,radiation therapy strategies,prevention of anthracycline cardiotoxicity,beta blocker or/and angiotensin converting enzyme inhibitor/angiotensin Ⅱ receptor blocker and statin cardioprotective effects. |
| |
| Keywords: | Breast cancer Radiotherapy and chemotherapy Anthracyclines Trastuzumab Cardiotoxicity Primary prevention |
| 本文献已被 CNKI 维普 等数据库收录！ |
